Q2 2025 Nath Bio-Genes (I) Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to FY '25 Nath Bio-Genes' Limited conference call, hosted by Go India Advisors. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Deepika Sharma from Go India Advisors. Thank you, and over to you, ma'am.
Good evening, everyone, and welcome to the Q2 and H1 FY '25 earnings call of Nath Bio-Genes Limited. We have on the call Mr. Satish Kagliwal, Managing Director; Dr. Devinder Khurana; Mr. Amol Gupta, Chief Financial Officer; Mr. Harish Pandey, Business Lead. We must remind you that the discussion on today's call may include certain forward-looking statements and must be therefore viewed in conjunction with the risk that the company made. May I now request the management to take us through the financials and the business outlook, subsequent to which we will be opening the floor for Q&A. Thank you, and over to you, sir.
- ()
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |